CHECK CAP LTD (CHEK) Stock Price, Quote, News and Overview
NASDAQ:CHEK - Nasdaq - IL0011336851 - Common Stock - Currency: USD
CHEK Quote, Performance and Key Statistics
CHECK CAP LTD
NASDAQ:CHEK (2/5/2025, 8:00:00 PM)
After market: 0.91 +0.02 (+2.24%)0.8901
-0.01 (-1.03%)
The current stock price of CHEK is 0.8901 USD. In the past month the price decreased by -34.07%. In the past year, price decreased by -59.54%.
CHEK Latest News, Press Releases and Analysis
Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket
CHEK Stock Earnings: Check-Cap Beats EPS for Q4 2023
CHEK stock results show that Check-Cap beat analyst estimates for earnings per share the fourth quarter of 2023.
CHEK Stock Earnings: Check-Cap Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Check-Cap (NASDAQ:CHEK) just reported results for the fourth quarter of 2023.Ch...
Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?
NeuBase Therapeutics stock is down on Tuesday as NBSE investors react to details concerning an upcoming special shareholder meeting.
Why Is Check-Cap (CHEK) Stock Up 44% Today?
Check-Cap stock is up on Tuesday with heavy trading as CHEK investors react to news of a business combination with Nobul AI.
CHEK Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.28 | 229.05B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.61 | 210.47B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.82 | 154.71B | ||
| SYK | STRYKER CORP | 32.74 | 152.14B | ||
| MDT | MEDTRONIC PLC | 17.46 | 117.57B | ||
| BDX | BECTON DICKINSON AND CO | 18.62 | 71.07B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27 | 42.52B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.66 | 39.83B | ||
| IDXX | IDEXX LABORATORIES INC | 41.65 | 38.36B | ||
| RMD | RESMED INC | 27.44 | 35.61B | ||
| DXCM | DEXCOM INC | 52.22 | 34.68B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 20.47 | 25.78B |
Related stock screener links
About CHEK
Company Profile
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule system for colorectal cancer screening. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
Company Info
CHECK CAP LTD
29 Abba Hushi Ave., P.O.Box 1271, Isfiya
Isfiya 3009000 IL
CEO: Alex Ovadia
Employees: 85
Company Website: https://check-cap.com/
Investor Relations: http://ir.check-cap.com/
Phone: 97248303401
CHEK FAQ
What is the stock price of CHEK?
The current stock price of CHEK is 0.8901 USD.
What is the symbol for CHECK CAP LTD stock?
The exchange symbol of CHECK CAP LTD is CHEK and it is listed on the Nasdaq exchange.
On which exchange is CHEK stock listed?
CHEK stock is listed on the Nasdaq exchange.
Is CHEK a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for CHEK, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of CHEK.
Does CHEK stock pay dividends?
CHEK does not pay a dividend.
What is the Price/Earnings (PE) ratio of CHEK?
CHEK does not have a PE ratio as the earnings reported over the last twelve months were negative (-3).
What is the Short Interest ratio of CHEK stock?
The outstanding short interest for CHEK is 5.93% of its float.
CHEK Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CHEK. When comparing the yearly performance of all stocks, CHEK is a bad performer in the overall market: 92.33% of all stocks are doing better.
CHEK Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CHEK. While CHEK has a great health rating, there are worries on its profitability.
CHEK Financial Highlights
Over the last trailing twelve months CHEK reported a non-GAAP Earnings per Share(EPS) of -3. The EPS decreased by 10.87% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -97.11% | ||
| ROE | -102.28% | ||
| Debt/Equity | 0 |
CHEK Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to CHEK. The Buy consensus is the average rating of analysts ratings from 6 analysts.